PARTNERING, STRATEGY & INVESTMENT FOR LIFE SCIENCE EXECUTIVE LEADERS
Connecting life science executives, strategics & investors
Sept 11-12, 2024
Hynes Convention Centre
Boston, MA, USA
See the brochure
Get event updates, offers & more!
What is the LSX Congress USA?
Global Head, Partnering & BD, Sanofi
VP Vice President, R&D - Patient Monitoring, Medtronic
VP of Corporate Development, Smith & Nephew
CEO, Flagship Pioneering
EVP, CBO, Ipsen
VP, Head of Data, Digital & Technology for Global Medical and Commercial, Takeda
Senior VP, Baxter
Venture Partner Takeda Digital Ventures
SVP, BD and M&A, BeiGene USA
Director, Digital Strategy and Innovation, Pfizer
Director, Global & U.S. Health Economics Market Access, Johnson & Johnson MedTech
Venture Partner, 3CC
VP, Venture Science, Eli Lilly
VP, Strategy & BD (M&A), Specialty Diagnostics Group, Thermofisher
Head of Consumer Strategy for Women’s Health, Philips
MD, Perceptive Advisors
5 reasons to choose LSX USA
LSX USA focuses almost exclusively on 3 main profiles – executives of life science and healthcare innovators (Biotech, Medtech and Healthtech), investors and large pharma/medtech. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment.
Meet the partners
I had the pleasure to participate in a great session. A unique opportunity for companies, big and small.
Our engagement with LSX has evolved into a trusted partnership which helps us connect with innovative and exciting companies in Europe and the US.
LSX creates a hugely meaningful forum for educating and networking with healthcare entrepreneurs.
Watch the LSX USA 2023 intro video